322014 VO Introduction to Evidence Based Pharmacy - M10 (2021W)
Labels
MIXED
Vorlesungszeiten:
Registration/Deregistration
Note: The time of your registration within the registration period has no effect on the allocation of places (no first come, first served).
Details
Language: German
Lecturers
Classes (iCal) - next class is marked with N
Monday
04.10.
16:45 - 18:15
UZA2 Hörsaal 5 (Raum 2Z202) 2.OG
Tuesday
05.10.
08:00 - 09:30
UZA2 Hörsaal 5 (Raum 2Z202) 2.OG
Wednesday
06.10.
16:45 - 18:15
UZA2 Hörsaal 5 (Raum 2Z202) 2.OG
Thursday
07.10.
08:00 - 09:30
UZA2 Hörsaal 5 (Raum 2Z202) 2.OG
Monday
11.10.
16:45 - 18:15
UZA2 Hörsaal 5 (Raum 2Z202) 2.OG
Tuesday
12.10.
08:00 - 09:30
UZA2 Hörsaal 5 (Raum 2Z202) 2.OG
Wednesday
13.10.
16:45 - 18:15
UZA2 Hörsaal 5 (Raum 2Z202) 2.OG
Thursday
14.10.
11:30 - 13:00
UZA2 Hörsaal 5 (Raum 2Z202) 2.OG
Wednesday
27.10.
08:00 - 09:30
UZA2 Hörsaal 7 (Raum 2Z210) 2.OG
UZA2 Hörsaal 8 (Raum 2Z206) 2.OG
UZA2 Hörsaal 8 (Raum 2Z206) 2.OG
Information
Aims, contents and method of the course
This lecture provides in-depth knowledge of evidence-based pharmacy, which enables students to make decisions in pharmaceutical care and counseling based on the application of the best possible evidence (clinical studies, therapy guidelines, pharmacovigilance).The knowledge acquired is used in the “Interpretation of Clinical Studies” UE that accompanies the lecture. A positive completion of the lecture examination is therefore a prerequisite for participation in the exercise "Interpretation of clinical studies".Depending on the situation, this lecture will be offered online via a webinar or as a face-to-face event. Current information on the lecture mode (online / presence) can be found at the beginning of the semester from the Moodle course of the same name!
Assessment and permitted materials
-) Written exam
-) Mixed examination mode: open questions and "multiple choice" questions
-) Exam duration: 60 min
-) Mixed examination mode: open questions and "multiple choice" questions
-) Exam duration: 60 min
Minimum requirements and assessment criteria
-) Number of questions: 12 questions
-) Maximum number of points: 12 pointsFor a positive assessment, you must achieve at least 3.5 points in both examination part 1 (Kampleitner) and examination part 2 (Kamyar).Clef: 12-11 (1), 10.75-10 (2), 9.75-8 (3), 7.75-7 (4), 6.75-0 (5)
-) Maximum number of points: 12 pointsFor a positive assessment, you must achieve at least 3.5 points in both examination part 1 (Kampleitner) and examination part 2 (Kamyar).Clef: 12-11 (1), 10.75-10 (2), 9.75-8 (3), 7.75-7 (4), 6.75-0 (5)
Examination topics
Script for the lecture (online: Moodle)
Reading list
1. “Fundamentals of Clinical Trials”, Autoren: Lawrence M. Friedman, Curt D. Furberg, David DeMets;
2. “Designing Clinical Research”, Autoren: Dr. Stephen B Hulley, MD, MPH, Steven R Cummings, MD, Warren S Browner, MD
3. “Practical Guide to Clinical Data Management”, Third Edition, Autoren: Susanne Prokscha
4. Study Design and Statistical Analysis: A Practical Guide for Clinicians; Autor: Mitchell Katz
5. Erfolgreich wissenschaftlich Arbeiten in der Klinik; Evidence Based Medicine; Autoren: Müllner, Marcus
6. Planning and Analyzing Clinical Trials with Composite Endpoints; Autoren: Rauch, Geraldine, Schüler, Svenja, Kieser, Meinhard
2. “Designing Clinical Research”, Autoren: Dr. Stephen B Hulley, MD, MPH, Steven R Cummings, MD, Warren S Browner, MD
3. “Practical Guide to Clinical Data Management”, Third Edition, Autoren: Susanne Prokscha
4. Study Design and Statistical Analysis: A Practical Guide for Clinicians; Autor: Mitchell Katz
5. Erfolgreich wissenschaftlich Arbeiten in der Klinik; Evidence Based Medicine; Autoren: Müllner, Marcus
6. Planning and Analyzing Clinical Trials with Composite Endpoints; Autoren: Rauch, Geraldine, Schüler, Svenja, Kieser, Meinhard
Association in the course directory
A231, A232, MA14
Last modified: Fr 01.04.2022 09:09